Geographic differences in implantable cardioverter defibrillator usage

Journal of Cardiovascular Electrophysiology

Volumn 13, Issue 1 SUPPL., 2002, Pages

  Seidl, Karlheinz ^a   Senges, Jochen ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Geographic differences; Implantable cardioverter defibrillator; Indication

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

BUDGET; CONFERENCE PAPER; DEFIBRILLATOR; EUROPE; EVIDENCE BASED MEDICINE; GEOGRAPHY; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEART ARRHYTHMIA; HEART DEATH; HUMAN; MORTALITY; PATIENT SELECTION; POLITICS; PRIORITY JOURNAL; TREATMENT INDICATION;

EID: 0036157869     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2002.tb01961.x     Document Type: Conference Paper

References (35)

1. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia: Multicenter Automatic Defibrillator Implantation Trial Investigators
2. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias
3. Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
4. Secondary prevention of sudden death: The Dutch Study, the Antiarrhythmics Versus Implantable Defibrillators Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study
5. Circumstances and causes of out-of-hospital cardiac arrest in sudden death survivors
6. A randomized study of the prevention of sudden death in patients with coronary artery disease: Multicenter Unsustained Tachycardia Trial Investigators
7. Antiarrhythmics Versus Implantable Defibrillators (AVID): Rationale, design, and methods
8. Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone
9. Implantable defibrillators and antiarrhythmic drugs in patients at risk for lethal arrhythmias
10. Sudden cardiac death
11. Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors: A randomized study
12. Risk indicators for out-of-hospital cardiac arrest in patients with coronary artery disease
13. Cardiac arrest and sudden death
14. Out-of-hospital cardiac arrest in the 1990's: A population-based study in the Maastricht area on incidence, characteristics and survival
15. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings
16. ICD clinical update: First decade, initial 10000 patients
17. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction
18. Drugs for ventricular arrhythmias in the era of the implantable cardioverter defibrillator
19. Prevention of implantable-defibrillator shocks by treatment with sotalol
20. The European Myocardial Infarction Trial (EMIAT)
21. Randomized trial of outcome after myocardial infarction with frequent or repetitive premature depolarisations: CAMIAT
22. Evidence rather than costs must guide use of the implantable cardioverter defibrillator
23. Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrhythmia specialists?
24. The ICD in France: Money problem or donkey syndrome?
25. Temporal and geographical trends in indications for implantation of cardiac defibrillators in Europe 1993-1998
26. Guidelines for the use of implantable cardioverter defibrillators
27. Potential impact of antiarrhythmic drugs versus implantable defibrillators on the management of ventricular arrhythmias: The Midlands trial of empirical amiodarone versus electrophysiologically guided intervention and cardioverter implant registry data
28. Hospitalization charges in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial: The AVID economic analysis study
29. Economic outcomes of implantable cardioverter-defibrillators
30. Cost effectiveness of the implantable cardioverter defibrillator
31. The cost-effectiveness of automatic implantable cardiac defibrillators: Results from MADIT. Multicenter automatic defibrillator implantation trial
32. Costs and functional consequences of U.S. roadway crashes
33. Cost-effectiveness analysis in heart disease, part III: Ischemia, congestive heart failure, and arrhythmias
34. An analysis of the cost-effectiveness of the implantable defibrillator
35. Unsustained ventricular tachycardia: To treat or not to treat?